分子动力学作为虚拟干选的工具
Grégory Menchon1, Laurent Maveyraud2, Georges Czaplicki3
1Inserm U1242, Oncogenesis, Stress and Signaling (OSS), Université de Rennes 1, Rennes, France.
Methods in molecular biology (Clifton, N.J.)
|September 7, 2023
概括
结合对接和分子动力学 (MD) 提高了合理的药物设计. 这种方法改进了蛋白质-连接体结合的预测,提高了效率并降低了药物发现中的实验成本.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 结构生物学是结构生物学.
背景情况:
- 合理的药物设计依赖于了解目标蛋白质结构.
- 虚拟带查 (VLS) 通过计算来识别潜在的药物候选者.
- 传统的对接方法在准确性和灵活性建模方面存在局限性.
研究的目的:
- 描述分子动力学 (MD) 作为VLS的辅助工具的作用.
- 突出将MD与基于结构的药物发现的对接集成的好处.
- 为了证明MD如何提高具有约束力的预测的准确性,并减少实验的努力.
主要方法:
- 利用分子动力学 (MD) 在对接之前或之后结合蛋白质的灵活性.
- 在现实的环境 (水,离子,膜) 中提炼蛋白质药物复杂结构.
- 采用MD进行更准确的绑定能量计算,以对潜在的候选药物进行排名.
主要成果:
- MD模拟提供了关键的蛋白质灵活性信息,而对接则缺乏这些信息.
- 精细化复杂结构,改善生物分子相互作用的时间描述.
- 将对接与MD结合起来,可以获得更可靠的亲和率估计和复杂的排名.
结论:
- 对接和MD的整合是现代基于结构的药物发现的强大策略.
- 这种综合方法显著提高了识别新疗法剂的效率.
- 在对接的同时使用MD减少了对广泛实验验证的需求.
关键词:
亲密关系 (Affinity) 是一种关系.集群集成是指集群集成.停靠对接 停靠对接药物设计 药物设计相互作用能量 相互作用能量分子动力学分子动力学蛋白合体复合体 蛋白合体复合体虚拟选是一个虚拟的选.更多相关视频
05:00Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
Published on: August 9, 2024
1.3K
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
318
相关概念视频
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
